NEW YORK, June 20, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Vojislav “Vojo” Vukovic as its new Chief Medical Officer (CMO). Dr. Vukovic is an experienced … Read more
SAN DIEGO, June 20, 2023 /PRNewswire/ — SuperMouth®, the first dentist-invented mouthcare system for kids, launches nationwide today at SuperMouth.com, kicking-off their Summer of Smiles program. Designed to focus on whole mouth health, SuperMouth is a revolutionary approach to oral care that includes the safest and most effective ingredients, parent-targeted educational resources, and branded entertainment content … Read more
NEW HAVEN, Conn.and MONMOUTH JUNCTION, N.J., June 20, 2023 /PRNewswire/ — DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it will present two posters at the Alzheimer’s Association International Conference (AAIC), taking place July 16 – 20, 2023, in Amsterdam, Netherlands, and online. Title: … Read more
New dispensary hosts grand opening event and expands patient access to medical cannabis TALLAHASSEE, Fla., June 20, 2023 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, announced the relocation of a medical dispensary in Fort Myers, Florida. Located at 5660 Bayshore … Read more
LOS ANGELES and ST. LOUIS, June 20, 2023 /PRNewswire/ — SteadyMD, a B2B telehealth infrastructure provider that powers high-quality telehealth patient experiences for leaders and innovators in healthcare, is pleased to announce that Andrew Slutsky, senior vice president of strategic marketing innovation at GoodRx, has joined its board of directors. “We’re thrilled to have Andrew Slutsky … Read more
– First FDA Breakthrough Therapy Designation granted for AdenoVerse immunotherapy platform; designation prioritizes PRGN-2012 as a potential treatment for RRP –– Designation based on positive Phase 1 clinical data that showed 50% of patients were “surgery-free” (Complete Response) after PRGN-2012 treatment with a minimum follow up of 12 months post-treatment – GERMANTOWN, Md. , June 20, … Read more
STOCKHOLM, June 20, 2023 /PRNewswire/ — The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi®) on 9 May 2023, resolved – for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programme for managers and executives (the Management Programme) resolved by the Annual General Meeting – on … Read more
Anthony Weston appointed as CEO of SUANNUTRA SUANNUTRA will enhance its presence in the global nutraceuticals market through strategic focus, product innovation and brand development. SUANNUTRA will continue as a customer focused business, developing market leading and award-winning products, investing in additional manufacturing, technical and R&D capabilities. Anthony Weston has been appointed as the CEO of … Read more
Fast-growing biopharma speeds commercial execution across Europe with Veeva Commercial Cloud BARCELONA, Spain, June 20, 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that ADVANZ PHARMA is standardizing commercial operations on Veeva Commercial Cloud as it expands in new markets across Europe. With a complete suite of Veeva software and data, ADVANZ can drive … Read more
DUBLIN, June 20, 2023 /PRNewswire/ — The “Membrane Chromatography – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Membrane Chromatography Market to Reach $1 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Membrane Chromatography estimated at US$373.7 Million in the year 2022, is projected to reach … Read more